新華醫療(600587.SH):公司提出的下肢助行外骨骼機器人的專利申請已由國家知識產權局受理
格隆匯5月7日丨新華醫療(600587.SH)在互動平臺表示,下肢助行外骨骼機器人適用於神經系統疾病(如腦卒中偏癱、脊髓損傷)、骨科術後(髖/膝關節置換、骨折)、老年肌少症及腦癱兒童等患者,覆蓋急性期被動訓練、恢復期主動輔助及慢性期抗阻訓練等全康復週期。該產品支持醫院、社區、家庭及養老機構等多場景應用,提供步態矯正、步行訓練等智能康復訓練模式。截至目前,公司提出的下肢助行外骨骼機器人的專利申請已由國家知識產權局受理。公司醫院級產品處於功能樣機研發階段。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.